Vasopressor and inotropic support in septic shock: An evidence-based review

Critical Care Medicine

Volumn 32, Issue 11 SUPPL., 2004, Pages

  Beale, Richard J ^a   Hollenberg, Steven M ^a   Vincent, Jean Louis ^b   Parrillo, Joseph E ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b VIVANTES KLINIKUM NEUKÖLLN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; HYPERTENSIVE FACTOR; NORADRENALIN; PHENYLEPHRINE;

ARTERIAL PRESSURE; ARTERY CATHETER; DRUG EFFECT; EVIDENCE BASED MEDICINE; HEART OUTPUT; HEMODYNAMIC MONITORING; HUMAN; HYPERLACTATEMIA; INFECTION; INOTROPISM; INTENSIVE CARE; MEAN ARTERIAL PRESSURE; OXYGEN SATURATION; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RESUSCITATION; REVIEW; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SURVIVAL;

CARDIOTONIC AGENTS; CATHETERIZATION; CONSENSUS DEVELOPMENT CONFERENCES; DOBUTAMINE; DOPAMINE; EVIDENCE-BASED MEDICINE; HUMANS; NOREPINEPHRINE; PRACTICE GUIDELINES; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 8444245918     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000142909.86238.B1     Document Type: Review

References (107)

1. Ronco JJ, Fenwick JC, Weeddale MG, et al: Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA 1993; 270:1724-1730
2. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
3. James JH, Luchette FA, McCarter FD, et al: Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 1999; 354:505-508
4. Boekstegers P, Weidenhofer S, Pilz G, et al: Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: Comparison to limited infection and cardiogenic shock. Infection 1991; 19:317-323
5. Kellum JA, Kramer DJ, Lee K, et al: Release of lactate by the lung in acute lung injury. Chest 1997; 111:1301-1305
6. De Backer D, Creteur J, Zhang H, et al: Lactate production by the lungs in acute lung injury. Am J Respir Crit Care Med 1997; 156:1099-1104
7. Maynard ND, Bihari DJ, Dalton RN, et al: Liver function and splanchnic ischemia in critically ill patients. Chest 1997; 111:180-187
8. Weil MH, Afifi AA: Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation 1970; 41:989-1001
9. Vincent JL, Dufaye P, Bene J, et al: Serial lactate determinations during circulatory shock. Crit Care Med 1983; 11:449-451
10. Friedman G, Berlot G, Kahn RJ, et al: Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis. Crit Care Med 1995; 23:1184-1193
11. Bakker J, Coffernils M, Leon M, et al: Blood lactate levels are superior to oxygen derived variables in predicting outcome in human septic shock. Chest 1991; 99:956-962
12. 2 in endotoxemic dogs during shock and resuscitation. J Appl Physiol 1994; 76:793-800
13. 2 extraction in the dog. J Appl Physiol 1987; 63:387-394
14. Schmidt H, Secchi A, Wellmann R, et al: Effect of endotoxemia on intestinal villus microcirculation in rats. J Surg Res 1996; 61:521-526
15. Farquhar I, Martin CM, Lam C, et al: Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. J Surg Res 1996; 61:190-196
16. Deitch EA: Bacterial translocation or lymphatic drainage of toxic products from the gut: What is important in human beings? Surgery 2002; 131:241-244
17. Russell JA: Gastric tonometry: Does it work? Intensive Care Med 1997; 23:3-6
18. Gutierrez G, Palizas F, Doglio G, et al: Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 1992; 339:195-199
19. Gomersall CD, Joynt GM, Freebairn RC, et al: Resuscitation of critically ill patients based on the results of gastric tonometry: A prospective, randomized, controlled trial. Crit Care Med 2000; 28:607-614
20. Silva E, De Backer D, Creteur J, et al: Effects of vasoactive drugs on gastric intramucosal pH. Crit Care Med 1998; 26:1749-1758
21. Weil MH, Nakagawa Y, Tang W, et al: Sublingual capnometry: A new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock. Crit Care Med 1999; 27:1225-1229
22. Marik PE, Bankov A: Sublingual capnometry versus traditional markers of tissue oxygenation in critically ill patients. Crit Care Med 2003; 31:818-822
23. Hollenberg SM, Ahrens TS, Astiz ME: Practice parameters for hemodynamic support of sepsis in adult patients. Crit Care Med 1999; 27:639-660
24. LeDoux D, Astiz ME, Carpati CM, et al: Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000; 28:2729-2732
25. Winslow EJ, Loeb HS, Rahimtoola SH, et al: Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med 1973; 54:421-432
26. Wilson RF, Sibbald WI, Jaanimagi JL: Hemodynamic effects of dopamine in critically ill septic patients. J Surg Res 1976; 20:163-172
27. Regnier B, Rapin M, Gory G, et al: Haemodynamic effects of dopamine in septic shock. Intensive Care Med 1977; 3:47-53
28. Drueck C, Welch GW, Pruitt BA: Hemodynamic analysis of septic shock in thermal injury: Treatment with dopamine. Am Surg 1978; 7:424-427
29. Samii K, Le Gall JR, Regnier B, et al: Hemodynamic effects of dopamine in septic shock with and without renal failure. Arch Surg 1978; 113:1414-1416
30. Jardin F, Gurdjian F, Desfonds P, et al: Effects of dopamine on intrapulmonary shunt fraction and oxygen transport in severe sepsis with circulatory and respiratory failure. Crit Care Med 1979; 7:273-277
31. Regnier B, Safran D, Carlet J, et al: Comparative haemodynamic effects of dopamine and dobutamine in septic shock. Intensive Care Med 1979; 5:115-120
32. Martin C, Papazian L, Perrin G, et al: Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103:1826-1831
33. Ruokonen E, Takala J, Kari A, et al: Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993; 21:1296-1303
34. Hannemann L, Reinhart K, Grenzer O, et al: Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock. Crit Care Med 1995; 23:1962-1970
35. Marik FE, Mohedin J: The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994; 272:1354-1357
36. Meier-Hellmann A, Bredle DL, Specht M, et al: The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Intensive Care Med 1997; 23:31-37
37. Neviere R, Mathieu D, Chagnon JL, et al: The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 1996; 154:1684-1688
38. Jakob SM, Ruokonen E, Rosenberg PH, et al: Effect of dopamine-induced changes in splanchnic blood flow on MEGX production from lidocaine in septic and cardiac surgery patients. Shock 2002; 18:1-7
39. Jakob SM, Ruokonen E, Takala J: Effects of dopamine on systemic and regional blood flow and metabolism in septic and cardiac surgery patients. Shock 2002; 18:8-13
40. De Backer D, Creteur J, Silva E, et al: Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best? Crit Care Med 2003; 31:1659-1667
41. Bailey AR, Burchett KR: Effect of low-dose dopamine on serum concentrations of prolactin in critically ill patients. Br J Anaesth 1997; 78:97-99
42. Van den Berghe G, de Zegher F, Lauwers P, et al: Growth hormone secretion in critical illness: Effect of dopamine. J Clin Endocrinol Metab 1994; 79:1141-1146
43. Van den Berghe G, de Zegher F, Lauwers P, et al: Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: Effect of dopamine. Clin Endocrinol 1994; 41:563-569
44. Van den Berghe G, de Zegher F, Lauwers P: Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol 1994; 41:731-737
45. Van den Berghe G, de Zegher F, Wouters P, et al: Dehydroepiandrosterone sulphate in critical illness: Effect of dopamine. Clin Endocrinol 1995; 43:457-463
46. Dive A, Foret F, Jamart J, et al: Effect of dopamine on gastrointestinal motility during critical illness. Intensive Care Med 2000; 26:901-907
47. Desjars P, Pinaud M, Potel G, et al: A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987; 15:134-137
48. Meadows D, Edwards JD, Wilkins RG, et al: Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988; 16:663-666
49. Hesselvik JF, Brodin B: Low-dose norepinephrine in patients with septic shock and oliguria: Effects on afterload, urine flow, and oxygen transport. Crit Care Med 1989; 17:179-180
50. Redl-Wenzl EM, Armbruster C, Edelmann G, et al: The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 1993; 19:151-154
51. Levy B, Bollaert FE, Charpentier C, et al: Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock. Intensive Care Med 1997; 23:282-287
52. Schreuder WO, Schneider AJ, Groeneveld ABJ, et al: Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Chest 1989; 95:1282-1288
53. Martin C, Saux P, Eon B, et al: Septic shock: A goal-directed therapy using volume loading, dobutamine and/or norepinephrine. Acta Anaesthesiol Scand 1990; 34:413-417
54. Brown RS, Carey JS, Mohr FA, et al: Comparative evaluation of sympathomimetic amines in clinical shock. Circulation 1966; 34:260-271
55. Fukuoka T, Nishimura M, Imanaka H, et al: Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate levels. Crit Care Med 1989; 17:1104-1107
56. Martin C, Eon B, Saux P, et al: Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 1990; 18:282-285
57. Martin C, Viviand X, Leone M, et al: Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28:2758-2765
58. McMillan M, Chernow B, Roth BL: Hepatic alpha I-adrenergic receptor alteration in a rat model of chronic sepsis. Circ Shock 1986; 19:185-193
59. Desjars P, Pinaud M, Bugnon D, et al: Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989; 17:426-429
60. Martin C, Perrin G, Saux P, et al: Effects of norepinephrine on right ventricular function in septic shock patients. Intensive Care Med 1994; 20:444-447
61. Mills LC, Moyer JH: The effects of various catecholamines on specific vascular hemodynamics in hypotensive and normotensive subjects. Am J Cardiol 1960; 5:652-659
62. Bellomo R, Kellum JA, Wisniewski SR, et al: Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med 1999; 159:1186-1192
63. Zhou SX, Qiu HB, Huang YZ, et al: Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock. Acta Pharmacol Sin 2002; 23:654-658
64. Reinelt H, Radermacher P, Fischer G, et al: Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 1997; 86:818-824
65. Bollaert FE. Bauer P, Audibert G, et al: Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine resistant shock. Chest 1990; 98:949-953
66. Lipman J, Roux A, Kraus P: Vasoconstrictor effects of adrenaline in human septic shock. Anaesth Intensive Care 1991; 19:61-65
67. Schaer GL, Fink MP, Parrillo JE: Norepinephrine alone versus norepinephrine plus low-dose dopamine: Enhanced renal blood flow with combination vasopressor therapy. Crit Care Med 1985; 13:492-496
68. Richer M, Robert S, Lebel M: Renal hemodynamics during norepinephrine and low-dose dopamine infusion in man. Crit Care Med 1996; 24:1150-1156
69. Bellomo R, Chapman M, Finfer S, et al: Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356: 2139-2143
70. Mackenzie SJ, Kapadia F, Nimmo GR, et al: Adrenaline in treatment of septic shock: Effects on hemodynamics and oxygen transport. Intensive Care Med 1991; 17:36-39
71. Wilson W, Lipman J, Scribante J, et al: Septic shock: Does adrenaline have a role as a first-line inotropic agent? Anaesth Intensive Care 1992; 20:470-474
72. Moran JL, O'Fathartaigh MS, Peisach AR, et al: Epinephrine as an inotropic agent in septic shock: A dose-profile analysis. Crit Care Med 1993; 21:70-77
73. Meier-Hellmann A, Reinhart K, Bredle DL, et al: Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 1997; 25:399-404
74. Day NPJ, Phu NH, Bethell DP, et al: The effects of dopamine and adrenaline infusion on acid-base balance and systemic hemodynamics in severe infection. Lancet 1996; 348:219-223
75. Levy B, Mansart A, Bollaert PE, et al: Effects of epinephrine and norepinephrine on hemodynamics, oxidative metabolism, and organ energetics in endotoxemic rats. Intensive Care Med 2003; 29:292-300
76. Gregory JS, Bonfiglio MF, Dasta JF, et al: Experience with phenylephrine as a component of the pharmacologic support of septic shock. Crit Care Med 1991; 19:1395-1400
77. Flancbaum L, Dick M, Dasta J, et al: A dose-response study of phenylephrine in critically ill, septic surgical patients. Eur J Clin Pharmacol 1997; 51:461-465
78. Reinelt H, Radermacher P, Kiefer P, et al: Impact of exogenous adrenoreceptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med 1999; 27:325-331
79. Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122-1125
80. O'Brien A, Clapp L, Singer M: Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359:1209-1210
81. Patel BM, Chittock DR, Russell JA, et al: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96:576-582
82. Dunser MW, Mayr AJ, Ulmer H, et al: Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study. Circulation 2003; 107: 2313-2319
83. Dunser MW, Mayr AJ, Tur A, et al: Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: Incidence and risk factors. Crit Care Med 2003; 31: 1394-1398
84. Vincent JL, Gris P, Coffernils M, et al: Myocardial depression characterizes the fatal course of septic shock. Surgery 1992; 111: 660-667
85. Vincent JL, Reuse C, Frank RN, et al: Right ventricular dysfunction in septic shock: Assessment by measurements of right ventricular ejection fraction using the thermodilution technique. Acta Anaesthesiol Scand 1989; 33:34-38
86. Parker MM, McCarthy KE, Ognibene FP, et al: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990; 97:126-131
87. Kumar A, Thota V, Dee L, et al: Tumor necrosis factor and interleukin Ib are responsible for in vitro myocardial depression induced by human septic shock serum. J Exp Med 1996; 183:949-958
88. Kumar A, Brar R, Wang P, et al: Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol 1999; 276: R265-R276
89. Jardin F, Sportiche M, Bazin M, et al: Dobutamine: A hemodynamic evaluation in human septic shock. Crit Care Med 1981; 9:329-332
90. Fisher CN, Horowitz Z, Albertson TE: Cardiorespiratory failure in toxic shock syndrome: Effect of dobutamine. Crit Care Med 1985; 13:160-165
91. Tell B, Majerus TC, Flancbaum L: Dobutamine in elderly septic shock patients refractory to dopamine. Intensive Care Med 1987; 13:14-18
92. Shoemaker WC, Appel PL, Kram HB, et al: Comparison of hemodynamic and oxygen transport effects of dopamine and dobutamine in critically ill surgical patients. Chest 1989; 96:120-126
93. Vincent JL, Roman A, Kahn RJ: Dobutamine administration in septic shock: Addition to a standard protocol. Crit Care Med 1990; 18:689-693
94. Colardyn FC, Vandenbogaerde JF, Vogelaers D, et al: Use of dopexamine hydrochloride in patients with septic shock. Crit Care Med 1989; 17:999-1003
95. Smithies M, Yee TH, Jacson L, et al: Protecting the gut and the liver in the critically ill: Effects of dopexamine. Crit Care Med 1994; 22:789-795
96. Hannemann L, Reinhart K, Meier-Hellmann A, et al: Dopexamine hydrochloride in septic shock. Chest 1996; 109:756-760
97. Meier-Hellmann A, Bredle DL, Specht M, et al: Dopexamine increases splanchnic blood flow but decreases gastric mucosal pH in severe septic patients treated with dobutamine. Crit Care Med 1999; 27:2166-2171
98. Barton P, Garcia J, Kouat HA, et al: Hemodynamic effects of IV milrinone lactate in pediatric patients with septic shock. Chest 1996; 109:1302-1312
99. Woo P, Carpenter MA, Trunkey D: Ionized calcium: The effect of septic shock in the human. J Surg Res 1979; 26:605-610
100. Malcolm DS, Zaloga GP, Holaday JW: Calcium administration increases the mortality of endotoxic shock in rats. Crit Care Med 1989; 17:900-903
101. Zaloga GP, Sager A, Black KW, et al: Low dose calcium administration increases mortality during septic peritonitis in rats. Circ Shock 1992; 37:226-229
102. Nasraway SA, Rackow EC, Astiz ME, et al: Inotropic response to digoxin and dopamine in patients with severe sepsis, cardiac failure, and systemic hypoperfusion. Chest 1989; 95:612-615
103. Bakker J, Gris P, Coffernils M, et al: Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg 1996; 171:221-226
104. Shoemaker WC, Appel PL, Kram HB, et al: Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988; 94: 1176-1186
105. Tuchschmidt J, Fried J, Astiz M, et al: Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 1992; 102:216-220
106. Hayes MA, Timmins AC, Yau EH, et al: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717-1722
107. Gattinoni L, Brazzi L, Pelosi P, et al: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995; 333:1025-1032